BORSARI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 346
AS - Asia 305
NA - Nord America 143
SA - Sud America 7
AF - Africa 3
Totale 804
Nazione #
IT - Italia 192
CN - Cina 146
US - Stati Uniti d'America 143
SG - Singapore 62
IN - India 41
DE - Germania 39
GB - Regno Unito 26
ID - Indonesia 25
CH - Svizzera 22
SE - Svezia 14
IE - Irlanda 9
FR - Francia 8
JP - Giappone 7
PT - Portogallo 7
HK - Hong Kong 6
KR - Corea 6
MY - Malesia 6
NL - Olanda 5
PL - Polonia 5
FI - Finlandia 4
AT - Austria 3
BE - Belgio 3
BR - Brasile 3
CO - Colombia 3
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
IR - Iran 2
NO - Norvegia 2
PK - Pakistan 2
RU - Federazione Russa 2
TW - Taiwan 2
CL - Cile 1
CZ - Repubblica Ceca 1
SC - Seychelles 1
Totale 804
Città #
Milan 74
Boardman 49
Monza 36
Singapore 34
Bengaluru 32
Beijing 25
Jakarta 25
Basel 16
Nuremberg 10
Dublin 9
Frankfurt am Main 9
Chandler 8
New York 8
Southend 8
West Jordan 8
Fairfield 6
Kuala Lumpur 6
Amsterdam 5
Guangzhou 5
Houston 5
Seattle 5
Wilmington 5
Edinburgh 4
Hong Kong 4
Lisbon 4
Roccapiemonte 4
Shanghai 4
Ashburn 3
Berlin 3
Braunschweig 3
Casale Monferrato 3
Chelmsford 3
Des Moines 3
Medellín 3
Oakland 3
St Louis 3
Vienna 3
Vitry-sur-seine 3
Warsaw 3
Wuhan 3
Aachen 2
Ann Arbor 2
Avezzano 2
Bergamo 2
Cattolica 2
Christchurch 2
Copenhagen 2
Eitensheim 2
Finstadjordet 2
Forlì 2
Genoa 2
Gorgonzola 2
Helsinki 2
Himmelried 2
Hyderabad 2
Incheon 2
Ioannina 2
Ishie 2
Islamabad 2
Jinhua 2
Kesswil 2
Lappeenranta 2
Legnano 2
Leipzig 2
Longyan 2
Ludhiana 2
Maranello 2
Medea 2
Naples 2
Newcastle-under-Lyme 2
Nora Springs 2
Norwich 2
Obihiro 2
Orlando 2
Parma 2
Pavia 2
Pioltello 2
Piscataway 2
Princeton 2
Póvoa de Varzim 2
San Giuliano 2
Sant'Ambrogio di Valpolicella 2
Strasbourg 2
Taipei 2
Tamatsukuri 2
Tehran 2
Vaiano Cremasco 2
Wuxi 2
Yongin-si 2
Americana 1
Atlanta 1
Bologna 1
Brno 1
Brooklyn 1
Calcinate 1
Carate Brianza 1
Chengdu 1
Chiavari 1
Chiswick 1
Chongqing 1
Totale 556
Nome #
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign 166
Chemo-enzymatic flow synthesis of tyrosol and hydroxytyrosol carbonates and carbamates as novel antiradical and antimicrobial agents 57
Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives 51
Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents 42
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K 36
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 36
Compounds having antiparasitic activity 26
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS 22
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 22
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs 21
null 20
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα 20
Disease related mutations in PI3Kgamma disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors 20
Stereospecific Synthesis of Substituted Sulfamidates as Privileged Morpholine Building Blocks 19
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 19
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives 17
Understanding Intrinsic Warhead Reactivity and Cysteine Druggability in Covalent Drug Discovery 17
The Facets of Diversity: The EFMC Perspective 16
Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability 15
Covalent Proximity Scanning of a Distal Cysteine to Target PI3Kα 15
Targeting Phosphoinositide 3-Kinase – Five Decades of Chemical Space Exploration 15
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 14
A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor 14
(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class i PI3K and mTOR Kinase 14
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor 14
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity 13
Design, synthesis and antiparasitic evaluation of click phospholipids 13
4-(Difluoromethyl)-5-(4-((3 R,5 S)-3,5-dimethylmorpholino)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)pyridin-2-amine (PQR626), a Potent, Orally Available, and Brain-Penetrant mTOR Inhibitor for the Treatment of Neurological Disorders 13
Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond 13
Chemical and Structural Strategies to Selectively Target mTOR Kinase 13
Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents 12
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology 12
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 12
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 11
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity 11
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 11
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders 11
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics 11
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent 11
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class i PI3K/mTOR Inhibitor as Clinical Candidate in Oncology 10
Scalable, Economical, and Practical Synthesis of 4-(Difluoromethyl)pyridin-2-amine, a Key Intermediate for Lipid Kinase Inhibitors 10
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 10
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 9
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety 9
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 9
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 9
Boosting the Impact of EFMC Young Scientists Network Through the Creation of Working Groups 8
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 8
Two-drug trick to target the brain blocks toxicity in the body 8
Excited-state intramolecular proton transfer in a bioactive flavonoid provides fluorescence observables for recognizing its engagement with target proteins 8
Target-based approaches for the discovery of new antimycobacterial drugs 8
TRIAZINE DERIVATIVE AS COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS KOVALENTE INHIBITOREN VON PI3K] 5
YMCC and YSN: An Opportunity for Scientific and Cultural Exchange 4
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K | [TRIAZINDERIVAT ALS REVERSIBLE UND IRREVERSIBLE KOVALENTE PI3K-HEMMER] 3
TRIAZINE DERIVATIVE AS REVERSIBLE AND IRREVERSIBLE COVALENT INHIBITORS OF PI3K 3
METHOD FOR IDENTIFYING PI3 KINASE-ALPHA INHIBITORS | [VERFAHREN ZUR IDENTIFIZIERUNG VON PI3-KINASE-ALPHA-INHIBITOREN] 3
Totale 1.019
Categoria #
all - tutte 6.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/202151 2 7 0 6 5 5 4 5 7 2 8 0
2021/202239 2 2 4 8 5 0 3 2 2 0 7 4
2022/202364 4 3 2 3 3 7 4 2 5 1 25 5
2023/2024814 3 7 5 44 181 107 84 20 59 81 104 119
2024/202544 44 0 0 0 0 0 0 0 0 0 0 0
Totale 1.019